[Metabolic syndrome in workers in a university hospital].

Introduction: Metabolic syndrome (MS) is a major health problem, and has economic effects on enterprises. The workplace is thus an important environment for primary prevention of risk factors for cardiovascular disease.

Objective: To determine the prevalence of MS and variables related to its development in hospital workers.

Construction and validation of the CADE-Q for patient education in cardiac rehabilitation programs.

Background: Being aware of the coronary artery disease can be considered the first step to reduce the risk of cardiac complications.

Objective: Building and validating a tool to assess and describe coronary patients' awareness in cardiac rehabilitation programs, with the purpose of education.

Methods: For the construction, we analyzed articles and field studies to submit items to multidisciplinary team associated to cardiac rehabilitation.

Metabolic abnormalities, antiretroviral therapy and cardiovascular disease in elderly patients with HIV.

One of the most recent phenomena related to the acquired immunodeficiency syndrome (AIDS) is the emergence of a new vulnerable population: the elderly. One of the factors that account for this increase is the development of combination antiretroviral therapy (ART), which has provided better quality of life and life expectancy for HIV-positive patients. However, ART is associated with adverse effects such as dyslipidemia, diabetes mellitus and insulin resistance, which are risk factors for cardiovascular disease.

Impact of metabolic syndrome and C-reactive protein on outcome after coronary stenting.

Metabolic syndrome (MS) identifies cardiovascular risk; however, there is little information regarding the evolution of patients with MS after stent implantation. The aim of this single-center study is to evaluate the possible association between MS and clinical restenosis, after adjustment for highsensitivity C-reactive protein (hs-CRP) and angiographic predictors of restenosis. In a longitudinal study, 159 patients (89 with and 70 without MS) were studied.

Peculiarities of ischemic heart disease treatment in the elderly.

Considering that the world's population average age is increasing and the proportions of those over the age of 80, the fastest growing population worldwide, new approaches to health care and treatment will be necessary. Due to the development of new drugs and by means of transluminal coronary angioplasty or coronary artery bypass graft, many elderly patients had their lives prolonged and their quality of life improved. We carried out a bibliography review to search for evidence to support the best treatment choice according to the clinical manifestation of the patient.